Of the 10 individuals with loss of MSH2 by IHC and PV positive in this cohort, 5 harbored PVs in genes other than MSH2. These findings suggests that IHC-guided single gene testing can extend the patient’s diagnostic journey, potentially miss a Lynch syndrome diagnosis, and delay appropriate medical management. The gene discussed is MSH2; the disease is acquired polycythemia vera.